Results 111 to 120 of about 5,798 (217)

Reversible G2 block in the cell cycle of Ehrlich ascites carcinoma cells

open access: yes, 1991
Using flow cytometry we found that proliferation of Ehrlich ascites carcinoma (EAC) cells has been reversibly arrested in the second half of the G2 period at the plateau phase of tumor growth in vivo. The ratio of G2/G1 cells increased from 0.3 at 6 days
Medvedeva, N. D.   +2 more
core   +1 more source

Effects of green synthesised silver nanoparticles (ST06-AgNPs) using curcumin derivative (ST06) on human cervical cancer cells (HeLa) in vitro and EAC tumor bearing mice models

open access: yesInternational Journal of Nanomedicine, 2019
Kalaimathi Murugesan,*,1 Jinsha Koroth,*,1,2 Padma Priya Srinivasan,1 Amrita Singh,3 Sanjana Mukundan,1 Subhas S Karki,4 Bibha Choudhary,1 Chhitar M Gupta11Institute of Bioinformatics and Applied Biotechnology (IBAB), Bangalore, India; 2Department ...
Murugesan K   +7 more
doaj  

A 9-aminoacridine derivative induces growth inhibition of Ehrlich ascites carcinoma cells and antinociceptive effect in mice. [PDF]

open access: yesFront Pharmacol, 2022
Mangueira VM   +14 more
europepmc   +1 more source

Effect of Theobroma cacao L. on the Efficacy and Toxicity of Doxorubicin in Mice Bearing Ehrlich Ascites Carcinoma. [PDF]

open access: yesAntioxidants (Basel), 2022
Patil PP   +6 more
europepmc   +1 more source

Acetylsalicylic Acid with Ascorbate: A Promising Combination Therapy for Solid Tumors

open access: yesDrugs in R&D
Background and Objective Cancer is a deadly disease with high mortality rates in developing countries. A recent preclinical study found promising results in treating hepatocellular carcinoma (HCC) by combining acetylsalicylic acid (ASA) and ascorbate (AS)
Nada M. El Ezaby   +2 more
doaj   +1 more source

Core-Shell Fe3O4@C Nanoparticles for the Organic Dye Adsorption and Targeted Magneto-Mechanical Destruction of Ehrlich Ascites Carcinoma Cells. [PDF]

open access: yesMaterials (Basel), 2022
Ivanova OS   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy